Vis enkel innførsel

dc.contributor.authorØverbø, Joakim
dc.contributor.authorAziz, Asma
dc.contributor.authorZaman, K.
dc.contributor.authorClemens, John
dc.contributor.authorJulin, Cathinka Halle
dc.contributor.authorQadri, Firdausi
dc.contributor.authorStene-Johansen, Kathrine
dc.contributor.authorBiswas, Rajib
dc.contributor.authorIslam, Shaumik
dc.contributor.authorBhuiyan, Taufiqur Rahman
dc.contributor.authorHaque, Warda
dc.contributor.authorSandbu, Synne
dc.contributor.authorElahee, Manzoor E
dc.contributor.authorAli, Mohammad
dc.contributor.authorDembinski, Jennifer Lynn
dc.contributor.authorDudman, Susanne
dc.date.accessioned2023-02-27T09:39:12Z
dc.date.available2023-02-27T09:39:12Z
dc.date.created2023-02-06T09:44:36Z
dc.date.issued2023
dc.identifier.citationVaccine. 2023, 41 1059-1066.
dc.identifier.issn0264-410X
dc.identifier.urihttps://hdl.handle.net/11250/3054108
dc.language.isoeng
dc.titleImmunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial
dc.title.alternativeImmunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1059-1066
dc.source.volume41
dc.source.journalVaccine
dc.identifier.doi10.1016/j.vaccine.2022.12.064
dc.identifier.cristin2123187
dc.relation.projectNorges forskningsråd: 248143
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel